Wolverine Trading, LLC Ocugen, Inc. Call Options Transaction History

Wolverine Trading, LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$0.98 - $1.95 $60,662 - $120,705	61,900 New	61,900 $61,000
Q1 2024 May 15, 2024	BUY	$0.5 - $1.83 $49,250 - $180,255	98,500 New	98,500 $161,000
Q4 2022 Feb 14, 2023	BUY	$1.11 - $1.87 $178,266 - $300,322	160,600 New	160,600 $209,000
Q2 2022 Aug 15, 2022	SELL	$1.83 - $3.45 $449,448 - $847,320	-245,600 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.34 - $4.72 $574,704 - $1.16 Million	245,600 New	245,600 $828,000
Q4 2021 Feb 14, 2022	SELL	$4.38 - $15.67 $1.38 Million - $4.95 Million	-316,200 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$6.36 - $8.51 $660,804 - $884,189	-103,900 Reduced 24.73%	316,200 $2.16 Million
Q2 2021 Aug 06, 2021	BUY	$5.52 - $15.68 $2.32 Million - $6.59 Million	420,100 New	420,100 $3.55 Million

125

78.4M

535K

523K

Ticker OCGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,566,000
Market Cap $158M
Description
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.